Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation
Alan S. Go(Kaiser Permanente), Daniel E. Singer(Massachusetts General Hospital), Yuchiao Chang(Harvard University), Angela M. Capra(Harvard University), Elaine M. Hylek(Boston University), Nancy G. Jensvold(Kaiser Permanente), Kathleen A. Phillips(Kaiser Permanente), Joe V. Selby(Kaiser Permanente), Lori Henault(Kaiser Permanente)
Cited by 708
Related Papers
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
|New England Journal of Medicine|2004|11.4k
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Prevalence of Diagnosed Atrial Fibrillation in Adults
|JAMA|2001|6.2k
Heart Disease and Stroke Statistics—2013 Update
|Circulation|2012|5.2k